Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Fischer, Angela; Bastian, Sara; Cogliatti, Sergio; Mey, Ulrich; Saub, Jenny; Schanz, Urs; Padberg, Barbara; Hohloch, Karin (2018). Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome. Hematological oncology, 36(1):370-371.

Hitz, Felicitas; Zucca, Emanuele; Pabst, Thomas; Fischer, Natalie; Cairoli, Anne; Samaras, Panagiotis; Caspar, Clemens B; Mach, Nicolas; Krasniqi, Fatime; Schmidt, Adrian; Rothermundt, Christian; Enoiu, Milica; Eckhardt, Katrin; Berardi Vilei, Simona; Rondeau, Stephanie; Mey, Ulrich (2016). Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08. British Journal of Haematology, 174(2):255-263.

Volk, Viktoria; Cathomas, Richard; Mark, Michael; von Moos, Roger; Klingbiel, Dirk; Brossart, Peter; Mey, Ulrich (2016). Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience. Supportive Care in Cancer, 24(5):2119-2128.

Samaras, Panagiotis; Bargetzi, Mario; Betticher, Daniel C; Duchosal, Michel A; Heim, Dominik; Hess, Urs; Ketterer, Nicolas; Lerch, Erika; Matthes, Thomas; Mey, Ulrich; Pabst, Thomas; Taverna, Christian; Zander, Thilo; Renner, Christoph (2015). Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. Swiss Medical Weekly, 145:w14100.

Hitz, Felicitas; Diem, Stefan; Haile, Sarah R; Ess, Silvia; Cerny, Thomas; Mey, Ulrich (2014). Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematological oncology, 32(4):192-196.

This list was generated on Mon Oct 22 03:06:49 2018 CEST.